BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2015
View Archived Issues
GANT-61 induces remyelination in mouse models of multiple sclerosis
Read More
Bionomics and Merck & Co. extend collaboration for pain medications
Read More
177Lu-DOTATATE improves progression-free survival in midgut NET patients
Read More
Study reveals selenoprotein P as a potential marker of insulin sensitivity
Read More
University of Pennsylvania reports AAVs expressing human OTC
Read More
Molecular Templates collaborates with MD Anderson Cancer Center on MT-3724
Read More
IGF-I and insulin may promote pancreatic cancer
Read More
UCB reports results from trial comparing Vimpat to Tegretol Retard in epilepsy
Read More
BlinkBio forms discovery collaboration with Janssen Pharmaceuticals
Read More
Caribou Biosciences and DuPont partner to develop CRISPR-Cas technology
Read More
Roche to acquire Adheron Therapeutics
Read More
Control of CAR T-cell therapy using heterodimerization stimulated by a small molecule
Read More
Sebacia completes enrollment in trial of acne treatment
Read More
CF-102 receives EMA orphan drug designation for HCC
Read More
Universiteit Antwerpen patents KLK4 inhibitors
Read More
Development of Lilly's evacetrapib terminated due to insufficient efficacy
Read More
Takeda Pharmaceutical develops PKC theta inhibitors
Read More
Changzhou Jiekai Pharmatech discloses AXL inhibitors
Read More
Efficacy and safety of MT-1303 in RRMS
Read More
Concert Pharmaceuticals earns milestone from Celgene for CTP-730
Read More
Ocrelizumab: results from ORATORIO study
Read More
Astellas Pharma and Immunomic Therapeutics partner for LAMP-vax products
Read More
FDA awards breakthrough therapy designation to RBX-2660 for recurrent C. difficile infection
Read More
FDA approves Opdivo for non-squamous NSCLC
Read More
Dynavax begins trial evaluating SD-101 in combination with Keytruda
Read More
EBOVAC-Salone trial begins in Sierra Leone
Read More